Insider Transactions in Q3 2024 at Eye Point Pharmaceuticals, Inc. (EYPT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2024
|
Goran Ando |
BUY
Open market or private purchase
|
Direct |
5,000
+27.55%
|
$35,000
$7.95 P/Share
|
|
Aug 20
2024
|
Wendy F Dicicco |
BUY
Open market or private purchase
|
Direct |
2,567
+20.48%
|
$17,969
$7.79 P/Share
|
|
Aug 19
2024
|
Karen L. Zaderej |
BUY
Open market or private purchase
|
Direct |
12,500
+43.1%
|
$87,500
$7.98 P/Share
|
|
Aug 16
2024
|
Nancy Lurker |
BUY
Open market or private purchase
|
Direct |
3,173
+3.15%
|
$22,211
$7.88 P/Share
|
|
Jul 12
2024
|
David R Guyer |
SELL
Open market or private sale
|
Direct |
11,625
-86.27%
|
$116,250
$10.06 P/Share
|
|
Jul 12
2024
|
David R Guyer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,775
+32.24%
|
$29,325
$3.38 P/Share
|
|
Jul 11
2024
|
Karen L. Zaderej |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+33.33%
|
-
|
|
Jul 10
2024
|
Jay S. Duker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,059
-17.49%
|
$64,472
$8.69 P/Share
|
|
Jul 10
2024
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,666
+26.56%
|
-
|
|
Jul 10
2024
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
11,111
+10.52%
|
-
|